The Cancer Charity Industrial Complex

The television commercial follows a predictable script. A soft-voiced narrator. A child in a hospital bed. A toll-free number. The unmistakable implication that your credit card, right now, tonight, could make the difference between life and death. It is effective. It is also expensive. And it raises a question that most of us have probably felt but never quite put into words: where does all that money really go?

I started pulling on this thread recently, and what I found was more alarming than I expected.

I have a personal interest in this topic that goes beyond idle curiosity. I lost my father to brain cancer when he was just 51, and my mother died from intestinal cancer at only 48. These were not old people. They were taken early, and the loss was profound. I know we have made many important strides toward preventing, treating, and even curing some cancers in the decades since. But with the enormous investment of time, money, and research over the past 50 years, I can’t help but wonder whether there isn’t a more effective and efficient path to actually curing this disease — and whether the sprawling fundraising industry that has grown up around cancer is helping us get there, or quietly standing in the way.

The Scale of It

Most people assume there are a few dozen cancer charities out there. The actual number is stunning.

Nearly five thousand organizations. Twenty-six thousand paid employees. Eight billion dollars flowing in every year — and cancer still kills roughly 600,000 Americans annually. Those numbers demand scrutiny.

A few giants dominate the landscape. The top handful of organizations — Dana-Farber, the American Cancer Society, the Leukemia & Lymphoma Society, City of Hope — account for nearly two-thirds of all the money. The remaining 4,900-plus organizations are fighting over the rest, each maintaining its own staff, its own advertising budget, its own office space, its own corporate infrastructure. All of it duplicated, over and over, thousands of times.

That’s not a rhetorical question. It’s an economic one. Every dollar spent on a television commercial, a direct-mail campaign, a telemarketing call center, or a mid-level fundraising manager’s salary is a dollar that does not go toward finding a cure. When that overhead cost is multiplied across five thousand separate organizations, the waste becomes enormous.

And let’s be honest about who is actually writing the checks. It isn’t Bruce Springsteen. It isn’t the Hollywood millionaires or the Silicon Valley billionaires. Research consistently shows that charitable giving as a percentage of income is highest among lower and middle-income Americans — precisely the people who can least afford it, and who are most likely to have lost a family member to this disease and genuinely want to help. They deserve to know the truth about where their money goes.

The Good Ones

To be fair, some organizations do excellent work and manage their finances with integrity. The charity watchdog groups — Charity Navigator, CharityWatch, and the BBB Wise Giving Alliance — publish ratings based on what percentage of donations actually reach the intended programs. A general benchmark: reputable organizations spend at least 75% of their budget on programs, not overhead.

*St. Jude’s own figures. Independent analysis notes that ALSAC, the fundraising arm, consistently spends about 30% of revenue on fundraising and has accumulated $6 billion in net asset growth since 2019 — a legitimate question for donors to consider.

St. Jude deserves its reputation. It has helped push the childhood cancer survival rate in the U.S. from 20% when it opened in 1962 to more than 80% today. No family ever receives a bill for treatment, travel, housing, or food. That is a genuine and remarkable accomplishment.

Susan G. Komen is more complicated. While 73% of expenses go to “programs,” a donor who believes they’re funding a cure might be surprised: of $145 million in annual expenses, only $17.2 million went to actual breast cancer research. The rest went to patient navigation, financial assistance, and awareness programs — worthwhile, but not a cure.

The Bad Ones — and They Are Genuinely Scandalous

Now for the part that should make every donor angry.

A joint investigation by the Tampa Bay Times and the Center for Investigative Reporting identified the 50 worst charities in America. The percentages spent on actual direct aid ranged from 0% to a high of only 11.1%. The worst offenders paid more than 90% of everything collected directly to the solicitors who made the phone calls.

The Advertising Problem Nobody Talks About

Television networks do not give away airtime. A 30-second national spot can cost anywhere from tens of thousands to hundreds of thousands of dollars depending on the network and time slot. Multiply that across five thousand competing organizations, each trying to out-tug-your-heartstrings the others, and you begin to understand where much of that $8 billion annual river of money actually flows — into the pockets of ad agencies, TV networks, direct-mail houses, and telemarketing firms.

The people who profit most from cancer fundraising are often not researchers. They are the professional fundraising companies that contract with these organizations, frequently keeping 50, 60, even 90 cents of every dollar they collect as their fee. It is entirely legal. It is happening right now, tonight, during the commercial break you’re watching.

Meanwhile, the Bruce Springsteens and the Hollywood millionaires and the Silicon Valley billionaires — the people who could write a check that would fund a year of research without feeling it — give proportionally far less of their income to causes like these than the widow who sends in $25 a month because she lost her husband to pancreatic cancer. The tax code rewards the wealthy donor handsomely, of course. But that is a different article.

The Watchdogs: Use Them Before You Give

The good news is that the tools to protect yourself exist and are free. Before donating to any cancer charity — or any charity at all — take two minutes and look it up at one of these three sites:

One additional warning from the watchdogs: many scam charities deliberately choose names that closely resemble legitimate ones. There is a legitimate, highly-rated “Breast Cancer Research Foundation” — and there was a low-rated, fraudulent “United Breast Cancer Foundation.” The names are almost identical. The performance was completely different. Never give based on name recognition alone.

A Final Thought

I want to be clear that many of the people working in cancer nonprofits are sincere, dedicated, and doing genuinely important work. The researchers, the patient navigators, the volunteers — the cause is real and the need is urgent. We have lost too many people we love to this disease.

But sincerity does not excuse inefficiency, and good intentions do not excuse duplication of effort on a massive scale. The question of whether 4,953 separate organizations, each with its own payroll and advertising budget and corporate structure, produces better cancer research outcomes than a smaller number of well-funded, focused institutions — that is a question worth asking loudly, and often.

The money is there. The donors are willing. The disease is beatable. The obstacle, at least in part, is the industry that has grown up around fighting it.

Check before you give. Your generosity deserves better than a fundraiser’s salary.